Bajaj Healthcare Ltd

Bajaj Healthcare Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Bajaj Healthcare Ltd

₹ 303 0.13%
24 May - close price
bajajhealth.com BSE: 539872 NSE: BAJAJHCARE
About

Established in the year 1993, Bajaj Healthcare Ltd is an estalished player in the Indian Pharmacuetical Industry and fastest growing mid-cap pharmaceutical companies in India.[1]

It is a bulk drug manufacturer manufacturing and supply of various Active Pharmaceutical Ingredients (API's), Amino acids and Nutritional supplements for Pharmaceuticals, Neutraceuticals, Food industries. [2]

Key Points

Product Portfolio
The Co. is into manufacturing and supply of API's, Intermediates, Formulations and Impurities. [1]
With 6 API manufacturing facilities spread across different states, API contributes around 90% to the overall revenue mix. It has a strong presence in more than 50 countries through exports of API's with an aggregate manufacturing capacity of 730 MT per month. [2]

Website BSE NSE
  • Market Cap ₹ 837 Cr.
  • Current Price ₹ 303
  • High / Low ₹ 513 / 245
  • Stock P/E 29.2
  • Book Value ₹ 101
  • Dividend Yield 0.33 %
  • ROCE 8.22 %
  • ROE 8.87 %
  • Face Value ₹ 5.00
Edit ratios

Pros

Cons

  • Stock is trading at 3.01 times its book value
  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of 5.04% over past five years.
  • Tax rate seems low
  • Company might be capitalizing the interest cost
  • Dividend payout has been low at 2.97% of profits over last 3 years

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
186 151 168 176 164 195 133 154 130 101 109 134
152 122 137 150 139 161 102 132 108 82 89 118
Operating Profit 33 29 31 25 24 34 30 22 22 19 20 16
OPM % 18% 19% 18% 14% 15% 18% 23% 14% 17% 19% 18% 12%
1 0 0 0 -2 -5 -6 -7 -55 -7 -7 -36
Interest 3 2 3 4 3 4 5 6 9 8 7 6
Depreciation 4 4 5 4 4 4 4 5 6 7 7 7
Profit before tax 27 22 23 17 16 22 15 5 -48 -3 -1 -33
Tax % 30% 22% 25% -3% 26% 26% 26% 21% 0% -4% -58% 10%
19 17 17 17 12 16 11 4 -48 -3 -2 -30
EPS in Rs 6.96 6.25 6.32 6.33 4.36 5.93 4.00 1.30 -17.47 -1.25 -0.80 -10.84
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
171 205 218 223 231 327 370 410 657 680 673 473
158 186 189 193 200 288 327 362 521 561 566 397
Operating Profit 13 19 29 30 31 39 43 48 136 119 107 76
OPM % 7% 9% 13% 14% 13% 12% 12% 12% 21% 17% 16% 16%
0 0 0 0 2 2 1 7 7 1 2 -105
Interest 6 7 8 8 8 8 8 7 8 13 23 30
Depreciation 8 9 9 9 11 11 11 12 16 18 27 28
Profit before tax -2 3 12 14 14 23 24 36 119 90 58 -86
Tax % 31% 40% 37% 39% 43% 33% 33% 30% 30% 20% 26% 3%
-1 2 8 8 8 15 16 25 83 71 43 -84
EPS in Rs -1.18 2.19 8.34 3.04 2.83 5.50 5.91 9.14 30.11 25.87 15.59 -30.36
Dividend Payout % 0% 0% 0% 0% 0% 5% 0% 0% 5% 6% 6% -3%
Compounded Sales Growth
10 Years: 9%
5 Years: 5%
3 Years: -10%
TTM: -30%
Compounded Profit Growth
10 Years: 31%
5 Years: 12%
3 Years: -30%
TTM: -33%
Stock Price CAGR
10 Years: %
5 Years: 29%
3 Years: -1%
1 Year: -1%
Return on Equity
10 Years: 17%
5 Years: 19%
3 Years: 15%
Last Year: 9%

Balance Sheet

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 2 2 2 7 7 7 7 14 14 14 14 14
Reserves 26 28 78 82 92 107 122 164 245 315 354 265
Preference Capital 2 2 2 0 0 0 0 0 0 0 0
70 70 69 81 75 87 81 91 181 257 415 333
33 45 40 39 45 68 57 74 86 136 119 154
Total Liabilities 131 145 189 209 219 268 267 343 526 721 901 765
54 56 108 130 128 127 128 162 208 270 366 255
CWIP 5 3 1 1 0 2 1 5 57 52 22 5
Investments 0 0 0 0 0 0 0 5 0 0 0 0
72 87 79 78 91 140 137 170 260 399 514 506
Total Assets 131 145 189 209 219 268 267 343 526 721 901 765

Cash Flows

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
14 17 28 25 22 17 25 21 44 1 -22 92
-8 -9 -17 -31 -8 -12 -13 -28 -109 -75 -93 -11
-7 -8 -11 5 -13 2 -13 3 75 62 132 -97
Net Cash Flow -0 1 -0 -0 0 7 -0 -4 10 -12 16 -16

Ratios

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 95 98 86 70 83 90 77 88 55 99 123 139
Inventory Days 43 51 50 56 45 57 45 54 94 143 191 206
Days Payable 51 68 63 46 51 74 45 80 67 94 78 128
Cash Conversion Cycle 87 81 73 80 78 73 77 62 82 148 237 217
Working Capital Days 71 62 52 52 58 61 66 76 90 142 204 254
ROCE % 5% 10% 16% 13% 13% 16% 16% 18% 36% 20% 12%

Shareholding Pattern

Numbers in percentages

2 Recently
Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
67.26% 67.26% 67.26% 67.26% 67.30% 67.30% 67.42% 67.49% 67.49% 67.69% 67.73% 67.74%
0.00% 0.34% 0.32% 0.38% 0.32% 0.09% 0.94% 0.78% 0.69% 0.66% 0.74% 0.53%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.34% 0.34% 0.34% 0.43% 0.48% 0.43%
32.74% 32.39% 32.42% 32.36% 32.38% 32.62% 31.30% 31.38% 31.48% 31.22% 31.06% 31.31%
No. of Shareholders 13,28326,70732,30930,72330,90929,76926,93026,03727,32228,00829,62632,712

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls

  • Jun 2022
    Transcript
    Notes
    PPT
  • Aug 2020
    Transcript
    Notes
    PPT